Literature DB >> 33243733

[Gene mutation analysis of 19 Uighur families with aortic disease in Kashgar, China].

Changjiang Yu1, Ying Li1,2, Abuduresuli Adilijang3, Jizhong Yan3, Arkin Guzalnur3, Abudula Abudushalamu3, Yimamu Aimirela3, Ruixin Fan1.   

Abstract

OBJECTIVE: To explore genetic mutation types and their correlation with clinical phenotypes in Uighur patients with aortic disease in Kashgar (Xinjiang Uighur Autonomous Region, China).
METHODS: We examined 37 pathogenic genes in 19 Uighur families with aortic diseases including Marfan syndrome from Kashgar using next generation sequencing, and the results were confirmed by Sanger sequence in the first relatives.
RESULTS: This study included 19 families with aortic diseases, in whom a total of 23 variants were identified, and 11 (57.89%) probands had one or more variants. Among them, definite pathogenic mutation was detected in one patient (5.26%), variants of uncertain significance (VUS) were found in 8 (42.11%), and benign/likely benign variants were detected in 7 (36.84%). The 23 variants identified included one (5.26%) pathogenic variant, 14 (60.87%) VUS, and 8 (34.78%) benign/likely benign variants. The 14 VUS were analyzed by prediction with SIFT and Polyphen2 HDIV, which identified 6 (42.86%) variants as deleterious/possibly damaging; all the 8 benign/likely benign variants were predicted to be deleterious/possibly damaging.
CONCLUSIONS: We detected 23 genetic variants in the 19 Uighur families with aortic diseases, and 22 of these variants remain to be verified by more patient data in future studies.

Entities:  

Keywords:  gene; next generation sequencing; thoracic aortic aneurysms; thoracic aortic dissection

Mesh:

Year:  2020        PMID: 33243733      PMCID: PMC7704366          DOI: 10.12122/j.issn.1673-4254.2020.11.11

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  30 in total

1.  Rare non-synonymous variations in the transcriptional activation domains of GATA5 in bicuspid aortic valve disease.

Authors:  Ratnasari Padang; Richard D Bagnall; David R Richmond; Paul G Bannon; Christopher Semsarian
Journal:  J Mol Cell Cardiol       Date:  2012-05-26       Impact factor: 5.000

2.  Genetic diagnosis of acute aortic dissection in South China Han population using next-generation sequencing.

Authors:  Jinxiang Zheng; Jian Guo; Lei Huang; Qiuping Wu; Kun Yin; Lin Wang; Tongda Zhang; Li Quan; Qianhao Zhao; Jianding Cheng
Journal:  Int J Legal Med       Date:  2018-07-28       Impact factor: 2.686

3.  FBN1 polymorphisms in patients with the dilatative pathology of the ascending thoracic aorta.

Authors:  Vaiva Lesauskaite; Ramune Sepetiene; Giedre Jariene; Vaiva Patamsyte; Giedrius Zukovas; Ingrida Grabauskyte; Zita Stanioniene; Raimondas Sirmenis; Rimantas Benetis
Journal:  Eur J Cardiothorac Surg       Date:  2015-01-12       Impact factor: 4.191

4.  Spectrum of mucocutaneous, ocular and facial features and delineation of novel presentations in 62 classical Ehlers-Danlos syndrome patients.

Authors:  M Colombi; C Dordoni; M Venturini; C Ciaccio; S Morlino; N Chiarelli; A Zanca; P Calzavara-Pinton; N Zoppi; M Castori; M Ritelli
Journal:  Clin Genet       Date:  2017-09-04       Impact factor: 4.438

5.  Routine Genetic Testing for Thoracic Aortic Aneurysm and Dissection in a Clinical Setting.

Authors:  Bulat A Ziganshin; Allison E Bailey; Celinez Coons; Daniel Dykas; Paris Charilaou; Lokman H Tanriverdi; Lucy Liu; Maryann Tranquilli; Allen E Bale; John A Elefteriades
Journal:  Ann Thorac Surg       Date:  2015-07-15       Impact factor: 4.330

6.  Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1.

Authors:  Scott A LeMaire; Merry-Lynn N McDonald; Dong-Chuan Guo; Ludivine Russell; Charles C Miller; Ralph J Johnson; Mir Reza Bekheirnia; Luis M Franco; Mary Nguyen; Reed E Pyeritz; Joseph E Bavaria; Richard Devereux; Cheryl Maslen; Kathryn W Holmes; Kim Eagle; Simon C Body; Christine Seidman; J G Seidman; Eric M Isselbacher; Molly Bray; Joseph S Coselli; Anthony L Estrera; Hazim J Safi; John W Belmont; Suzanne M Leal; Dianna M Milewicz
Journal:  Nat Genet       Date:  2011-09-11       Impact factor: 38.330

7.  Elastin: mutational spectrum in supravalvular aortic stenosis.

Authors:  K Metcalfe; A K Rucka; L Smoot; G Hofstadler; G Tuzler; P McKeown; V Siu; A Rauch; J Dean; N Dennis; I Ellis; W Reardon; C Cytrynbaum; L Osborne; J R Yates; A P Read; D Donnai; M Tassabehji
Journal:  Eur J Hum Genet       Date:  2000-12       Impact factor: 4.246

Review 8.  Aortic dissection.

Authors:  Christoph A Nienaber; Rachel E Clough; Natzi Sakalihasan; Toru Suzuki; Richard Gibbs; Firas Mussa; Michael P Jenkins; Matt M Thompson; Arturo Evangelista; James S M Yeh; Nicholas Cheshire; Ulrich Rosendahl; John Pepper
Journal:  Nat Rev Dis Primers       Date:  2016-07-21       Impact factor: 52.329

9.  Genetic diversity and pathogenic variants as possible predictors of severity in a French sample of nonsyndromic heritable thoracic aortic aneurysms and dissections (nshTAAD).

Authors:  Pauline Arnaud; Nadine Hanna; Louise Benarroch; Mélodie Aubart; Laurence Bal; Patrice Bouvagnet; Tiffany Busa; Yves Dulac; Sophie Dupuis-Girod; Thomas Edouard; Laurence Faivre; Laurent Gouya; Didier Lacombe; Maud Langeois; Bruno Leheup; Olivier Milleron; Sophie Naudion; Sylvie Odent; Maria Tchitchinadze; Jacques Ropers; Guillaume Jondeau; Catherine Boileau
Journal:  Genet Med       Date:  2019-02-11       Impact factor: 8.822

10.  Next-generation sequencing for diagnosis of thoracic aortic aneurysms and dissections: diagnostic yield, novel mutations and genotype phenotype correlations.

Authors:  J K Poninska; Z T Bilinska; M Franaszczyk; E Michalak; M Rydzanicz; E Szpakowski; A Pollak; B Milanowska; G Truszkowska; P Chmielewski; A Sioma; H Janaszek-Sitkowska; A Klisiewicz; I Michalowska; M Makowiecka-Ciesla; P Kolsut; P Stawinski; B Foss-Nieradko; M Szperl; J Grzybowski; P Hoffman; A Januszewicz; M Kusmierczyk; R Ploski
Journal:  J Transl Med       Date:  2016-05-04       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.